Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, November 17, 2022
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
[ Thu, Nov 17th 2022
] - WOPRAI
Jack Allen Maintained (TIL) at Buy with Decreased Target to $280 on, Nov 17th, 2022
Jack Allen of Baird, Maintained "Instil Bio, Inc." (TIL) at Buy with Decreased Target from $480 to $280 on, Nov 17th, 2022.
Jack has made no other calls on TIL in the last 4 months.
There are 3 other peers that have a rating on TIL. Out of the 3 peers that are also analyzing TIL, 2 agree with Jack's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $120 on, Tuesday, November 1st, 2022
- Yaron Werber of "Cowen & Co." Downgraded from Buy to Hold on, Tuesday, November 1st, 2022
This is the rating of the analyst that currently disagrees with Jack
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $320 on, Tuesday, August 23rd, 2022
